Recently, 420MEDIA CEO Kerri Accardi sat down with Tracy Lamourie for MJ News to discuss the exciting launch of her groundbreaking new venture A New Cannabis Channel.
Here’s a peek into that conversation:
TRACY LAMOURIE: You have been doing some amazing things in the media and the cannabis space, and now you are combining the two in a way that I don’t think people are seeing just how groundbreaking it is!
KERRI ACCARDI: Maybe that’s because we didn’t Press Release our every move!
TRACY: Right! But now you are finally ready to let some of the secrets out! Can you tell us a little bit about the exciting things you have got going right now?
KERRI: Absolutely! I’m the founder of 420MEDIA, a full-service marketing and content creation agency. Over the past 6 years we have been documenting the legalization of cannabis in the US. Currently we are in the process of launching a cannabis TV channel across ROKU, Apple TV, Firestick TV, Android TV, two mobile apps and online, with original programming, including a docu-series.
We are bringing education through entertainment with unprecedented opportunities for targeted advertising to cannabis and CBD companies. We are super excited to take a very fragmented space and streamline the information to the mainstream while showcasing products and services in a way the public has yet to see.
There are so many people that they hear about CBD or they hear about the benefits of cannabis, but they don’t know where to find a product or even worse they try a product that’s called CBD and it doesn’t work and right away they’re judging CBD as nonsense, but when you read the bottle it’s really hemp seed oil or something that doesn’t have CBD in it at all.
We really want to help guide people seeking knowledge. At the end of the day, we all have an endocannabinoid system with receptors for the plant on a molecular level. I don’t think the majority of people really understand that – and when they do it’s going to be a game changer.
TRACY: Absolutely- you’re talking education, you’re talking entertainment, the business of cannabis, literally anything relating to cannabis you will find on this channel. I know to bring something like this together doesn’t happen alone and you really have been able to gather an incredible team, some big names not just from cannabis but from the advertising world, from the world of marketing, from the world of media – you are bringing them all together, can you tell us about some of the people you have behind you and some of their experiences before joining you on this groundbreaking project in the world of cannabis.
KERRI: We have a phenomenal team that has come together absolutely from the mainstream industry. We have Emmy award winners; we have advertising executives – in fact the person who is creating our logo created one of the most iconic advertising campaigns I think ever in the world!
KERRI: We will put names and more information and promo out over the next few weeks.
TRACY: I’m excited to see this develop. Can you tell me some more about the content, and I know it is incredible – you have got people at the top of their industries from athletics to the medical fields, not just one doctor but probably ten from across America – can you tell us a little bit about the content and the experience of gathering that over the years? I know it is a literal library, or a museum of cannabis history over the last few years.
KERRI: Yes -we have a massive library of professionally filmed content – literally over 300 pioneers- on camera plus products, music, panels and speakers, and original programming.
Super bowl champion Marvin Washington hosts one of our series which explores cannabis from an athlete’s perspective. We have him in a CBD lab, pharmacy, events, as well as closed sets interviewing fellow NFL players and nurses – so it really is different insights coming through him.
Then we have another series hosted by a nurse and educator Heather Manus that is more geared to the medicinal side of the plant. What is the endocannabinoid system? Dosing, our receptors, what are the products and the different methods of ingestion and how does it affect us. Why is this plant working for people? We have another series called “Faces Of Cannabis” featuring over 30 pioneers sharing their story and insight into cannabis – from Wanda James who is on Netflix right now, to a child named Landon Riddle who is cancer free for seven years and he is nine years old to Dr Dina, the women the show “Weeds” was based on. We have a lot.
TRACY: I know you have spoken in the past about the personal part of your mission.
KERRI: It’s super simple. I left New York on December 10th, 2013 I left on a mission to educate the world about cannabis. My Aunt Kathy died. My best friend, my mentor, my everything. She died, and she didn’t have to. She definitely didn’t have to suffer like I watched.
I knew that no one would listen to me unless I knew what I was talking about, so I started at the bottom, literally – learning how to grow, meeting with patients, doctors, growers, lobbyists and more. This was back in 2013 in CA – it was a much different world.
In January 2014 NY quazi- legalized medical cannabis through executive order and thus 420MEDIA was born.
TRACY: What a journey. Somewhere your aunt is smiling down on you right now saying, ‘WOW! I inspired all this.’ You really are changing the world with this. That’s not just language, people are going to see that as this develops – it’s going to be epic.
KERRI: What people don’t understand is that cannabis isn’t new, this medicine isn’t new, even the cannabis industry isn’t new – it’s new in the regulated space. California has been legal-ish for over twenty years and has been helping thousands of people.
TRACY : Now let’s talk a little about the business of cannabis, and I know from a business perspective it’s often difficult to get your message out in the space, struggles around advertising, struggles around restrictions and limitations on social media, lots of barriers about getting your message out there that we don’t face in messaging with other consumer products. So what you are doing is absolutely valuable to people in the cannabis marketing space. Can you tell us a little bit about this really unprecedented advertising opportunity?
KERRI: Everything was born out of a problem, and the problem is that brands do not have a place to advertise consistently. I learned about this over the past 6 years of owning an agency and having different television deals and advertising opportunities. They can just change their mind and the rules and the pricing and all sorts of craziness. This was created to enhance cannabis brands and products and give them a place to advertise and share their information very similar to television and TV commercials and when we go back into production we will have opportunity for product placement and sponsorships, so it is a space that will literally give brands the opportunity to showcase their product in high level content that has a truly targeted audience – because you aren’t coming to this channel to watch a baseball game. You are coming to this channel to learn about cannabis
What’s the value of your athlete CBD cream being seen in a series hosted by a Super Bowl champion who also happens to have a case going to the Supreme Court over the legality of cannabis? What does it mean to have your brand showcased amongst medical professionals discussing the benefits of cannabis?
KERRI: Yes! What we are doing now, given the COVID-19 situation, is selling permanent placement in three of our series where we will build in commercials to showcase those brands and services. If you are in a series with Marv Washington, for example, you are in there forever. So, brands are getting multiple digital assets and a lifetime value. If they don’t have a commercial, we can have it created for a slight up-charge. If they do have a commercial, they can send it to us, and it will literally be edited in as if it was a part of that series. It is only for our inaugural series!
TRACY: So right now, anyone can get in on the ground floor, in there forever, they can basically write their own story right now as far as where they want to be. As a publicist and a marketing person, I’m definitely excited about this for my own brand and for my clients, it’s great to be able to get in on the very beginning.
DISTRICT OF COLUMBIA: Rep. Tulsi Gabbard (HI-02), a senior member of the House Armed Services Committee, secured an amendment to the annual national defense bill that would ensure that the U.S. Department of Defense may not prohibit the possession, use, or consumption of hemp products — in compliance with applicable Federal, State, and local law — by servicemembers. This would apply to hemp that meets the Agricultural Marketing Act of 1946 definition (amended by the Agricultural Improvement Act of 2018). The Gabbard amendment was included in the final version of the bill which passed on Tuesday, 295-125, and now goes to the Senate for consideration.
“There is great research being done around hemp, resulting in new products coming to market that are proven to help with ailments like insomnia, inflammation, chronic pain, epilepsy, Traumatic Brain Injury, Post-Traumatic Stress and more. Hemp products provide a form of treatment that serves as an alternative option for those who would rather pursue natural remedies rather than prescription drugs. This amendment passed with strong bipartisan support, ensuring our servicemembers have access to the same over-the-counter products that Americans all across the country benefit from today,” said Rep. Tulsi Gabbard.
The 2018 Farm Bill, known as the Agricultural Improvement Act, legalized hemp, defined as cannabis (Cannabis sativa L.) and derivatives of cannabis with extremely low concentrations of the psychoactive compound delta-9-tetrahydrocannabinol (THC) (no more than 0.3 percent THC on a dry weight basis). Currently, many over-the-counter products are sold that meet these parameters.
In its latest report on CBD Oil Market provides a concise analysis of the recent market trends. The report further includes statistics, market forecasts and revenue estimations, which in addition highlights its status in the competitive domain as well as expansion trends adopted by major industry players.
Cannabidiol Oil (CBD Oil) Market: Global Market Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025.Cannabidiol Oil Market is valued at USD 23.37 Million in 2018 and expected to reach USD 1068.54 Million by 2025 with the CAGR of 21.5% over the forecast period.
The detailed market intelligence report on the Global Cannabidiol Oil (CBD Oil) Market applies the most effective of each primary and secondary analysis to weighs upon the competitive landscape and also the outstanding market players expected to dominate Global Cannabidiol Oil (CBD Oil) Market place for the forecast 2019- 2025.
NORTH CAROLINA: Asheville Hemp Project (AHP), an Asheville, NC-based hemp cultivator, is announcing its new product line. The company is also announcing that it is donating 50% of online sales to the NC Restaurant Workers Relief Fund.
Leslie Hoffman, co-founder of AHP, stated, “We are very excited about our new product offerings that are coming onto the market at this time. We are also very concerned about the fate of our community during the pandemic. Much of the economy of the greater Asheville area relies on the hospitality sector, and with all non-essential businesses closed, most restaurant workers are staying home with no idea of when, or if, they will have their jobs again. For that reason, we are contributing 50% of every purchase to the NC Restaurant Workers Relief Fund.”
The AHP tagline is “Take a Moment: Look Inward, Look Outward, Look Homeward.” Thomas Wolfe wrote Look Homeward, Angel about Asheville in 1929, and we have taken home to reference not only a safe physical place, but also a calm, restful, comfort that we all need. Our CBD products soothe and satisfy and provide an aid in these stressful times.
AHP is bringing four new products to market, each designed to fill a niche space in the consumer market.
Pre-Rolls: Grown on the AHP farm – premium hemp flower is consistently rolled in unbleached hemp paper with a unique biodegradable crutch. No need to filter out the reason you smoke. Immediate beneficial effect, and also a great way to ease off tobacco and nicotine. This 10-pack always ensures having a soothing and relaxing smoke on hand. 100mg CBD in each pre-roll provides a smoke on hand at all times. <.3% THC.
AHP Extract: Straight from the AHP farm, this full spectrum hemp extract is in a 1 oz (30ml) tamper-proof bottle with calibrated dropper. The extract is available in 1000 mg and 1500 mg options. The CBD is blended with olive oil to provide a high quality dose of CBD in a pleasing flavor that mixes with food easily. <.3% THC.
Lip Balm: AHP’s Organic Hemp Lip Balm is formulated to be ultra-soothing and nutrient rich. Made with certified organic ingredients, such as hemp oil, sunflower oil, and beeswax, the lip balm provides all-natural protection. THC and CBD free.
Gum: AHP gum has been formulated to provide the quickest — and perfectly dosed — release of CBD, with increased bio-availability. The convenient sealed package protects freshness and enables the most discreet way to consume at any time. 8 pieces/pk, 10mg CBD in each piece, and THC free.
The NC Restaurant Workers Relief Fund has been established and is managed through the North Carolina Restaurant and Lodging Association Foundation, a 501(c)(3) that has provided financial assistance to hospitality employees and students for more than a decade.
The goal of the NC Restaurant Workers Relief Fund is to provide immediate financial assistance to the tens of thousands of cooks, servers, dishwashers, housekeepers, and others who live paycheck-to-paycheck, and suddenly find themselves in distress.
For more information visit the Fund’s website at https://www.ncrestaurantrelief.com
As CBD continues to gain massive popularity across the globe, its fanatic fans don’t shy away from coming up with interesting ways to consume it. Luckily, CBD stands concrete with a market worth of over $1 billion, which is expected to cross the $5 billion mark near future. If you’re looking for one of the purest forms of CBD, we’re glad to have you here. So what exactly is CBD isolated? And what are its benefits? Here we will guide you through a quick tour of this compound.
What is CBD Isolate?
In simple words, CBD isolate is pure crystal powder that is 99% of pure CBD. This compound is only dominated by CBD. After the plant goes through the process of getting filtered from plants, waxes, chlorophyll, and oil, a finished product is CBD and nothing else.
How is it Made?
If you want to get pure CBD to isolate from hemp, it should be extracted. However, manufacturers have to go the extra mile to produce CBD isolate in its purest form. The process is very much like any other process of CBD products. The intriguing thing to note is, once the extraction is done, the concentrated material is still packed with plant nutrients. So if you want to get pure CBD, you need to make it go through a purifying process. The purification process is simple and filters out all the material. After this process, the oil is made to go through a winterization process, which further breaks down any kind of waxes and remaining plant materials. So now you’re left with 99% CBD, which is in its purest form.
How to Use CBD Isolate?
Now that you have chosen a CBD isolate, you must be wondering how to use it. In simple words, you can do anything you like. This is because CBD isolates don’t have any odor or taste, so people can use it in a variety of ways. Some of the common uses of CBD isolate consists of:
- Infuse it in Food Items
You will be surprised to know a lot of CBD fans love to infuse it in food items. Fanatic CBD fans often like to prepare dishes with CBD because it is helpful in treating several health conditions. If you want pure CBD, you can buy from industrialhempfarms.com.
- Mix it in Juices and Smoothies
One of the coolest and easiest ways is to add CBD to a glass of smoothie or drink. The most interesting benefit of CBD smoothies is, you can get the maximum benefit of this compound In liquid form. If you visit countryside American bars, you will be served cups of CBD tea and smoothies for as low as $5.
- Make Desserts With It
CBD can also be used in making chocolate chip cookies and brownies at home. If your loved ones are big CBD fans, you can infuse this compound in desserts to get an amazing experience. Although CBD desserts can easily be made at home, there are several vendors that sell CBD brownies online.
DISTRICT OF COLUMBIA: Over the past year, the U.S. Food and Drug Administration has embarked on a comprehensive evaluation of cannabidiol (CBD) products, with a focus on educating the public about the risks and unknowns of these products, gathering the science needed to better understand both these safety concerns and potential benefits to inform our regulatory approach, as well as taking steps when necessary to address products that violate the law in ways that raise a variety of public health concerns.
Today, we are providing updates on our efforts in this area, including several new steps in areas of education, research and enforcement with the ultimate goal of continuing to protect the public health and working to provide market clarity.
Educating the Public About Potential Risks of Using CBD
We’re seeing CBD being marketed in a number of different products, such as oil drops, capsules, syrups, food products, such as chocolate bars and teas, cosmetics and other topical lotions and creams, as well as products marketed for pets and other animals – and we understand consumers are seeking out these novel products for a variety of perceived health-related or other reasons.
But as the agency has stated before, we are concerned that some people wrongly think that the myriad of CBD products on the market have been evaluated by the FDA and determined to be safe, or that using CBD ‘can’t hurt.’ Aside from one prescription drug approved to treat two rare, severe pediatric epilepsy disorders, no other CBD products have been evaluated or approved by the FDA.
We remain focused on educating the public about the number of questions that remain regarding CBD’s safety. There may be risks that need to be considered before using CBD products outside of the monitored setting of a prescription from your health care provider.
In particular, the agency recently updated the public on concerns about potential harm from CBD products, including potential liver injury, interactions with other drugs and male reproductive toxicity, as well as side effects such as drowsiness. In addition, there is still much we do not know about other potential risks. For example, other than the approved prescription drug, we know little about the potential effects of sustained and/or cumulative use of CBD, co-administration with other medicines, or the risks to vulnerable populations like children, pregnant and lactating women, the elderly, unborn children and certain animal populations. This does not mean that we know CBD is unsafe to these populations or under these circumstances, but given the gaps in our current knowledge, and the known risks that have been identified, we also are not at a point where we can conclude that unapproved CBD products are safe for use. We encourage Americans to consult with their health care providers before using CBD products.
We will continue to expand our educational efforts on this front. This includes consumers broadly, specific populations where there are additional, important health considerations, as well as health care professionals who must understand these risks when talking to their patients. We will also continue to update our online resources for consumers, researchers and industry, as well as sustain multiple lines of communication with Congress, industry, researchers and our regulatory partners at the federal, state, local, territorial, tribal and international levels to share and collect needed information and hear a variety of perspectives.
Closing Knowledge Gaps in Both Safety and Potential Benefits
The marketplace for CBD-containing products is quickly evolving and it is critical that we work together with stakeholders and industry to develop high-quality data to close the knowledge gaps about the science, safety and quality of many of these products, as well as further evaluate any potential benefits outside of the one FDA-approved drug product to treat two rare, severe pediatric epilepsy disorders.
To address the questions and concerns we’ve already raised, we’re seeking reliable and high-quality data. This includes data on, among other things: the sedative effects of CBD; the impacts of long-term sustained or cumulative exposure to CBD; transdermal penetration and pharmacokinetics of CBD; the effect of different routes of CBD administration (e.g., oral, topical, inhaled) on its safety profile; the safety of CBD for use in pets and food-producing animals; and the processes by which “full spectrum” and “broad spectrum” hemp extracts are derived, what the content of such extracts is, and how these products may compare to CBD isolate products.
Given the importance of answering these questions, we’re exploring a number of ways to address the data gaps as quickly as possible. This includes encouraging, facilitating and initiating more research on CBD, providing venues for industry and researchers to share new data with the agency and identifying opportunities to further collaborate with our federal partners at Centers for Disease Control and Prevention, Substance Abuse and Mental Health Services Administration and National Institute on Drug Abuse on this important issue.
Importantly, the Agriculture Improvement Act of 2018 – which, among other things, changed federal law so that cannabis and cannabis derivatives with very low levels of the psychoactive intoxicating component of cannabis, delta-9 tetrahydrocannabinol (THC) are no longer controlled substances – has opened significant new opportunities for research, and as that body of research develops and grows, there will be considerably more information available. In particular, there’s been an increased interest in drug development from CBD and other compounds found in cannabis and we are working to support drug development as much as possible.
First, given all the research and activity in this space, we are taking new steps to provide a public and transparent way for stakeholders to provide new and emerging information to us in real time as it becomes available. To this end, in the coming days we are re-opening the public docket we established for our May 2019 public hearing. The docket provides a valuable conduit for submission of scientific data on CBD to the agency, so we have decided to extend the comment period indefinitely to allow the public to comment and to share relevant data with the agency. As the agency continues to move forward to explore viable pathways for CBD products outside the drug context, this extension will allow stakeholders to continue to provide relevant data as research in this area evolves.
This docket also includes a mechanism for a stakeholder to submit data or information that the stakeholder believes to be confidential. We hope that this will enable responsible industry participants, academic researchers, and other stakeholders to share relevant information with the FDA – including information about specific products, which could help inform appropriate regulatory steps.
We also are working to generate data to help inform our work in this area. For example, the FDA’s Office of the Chief Scientist recently awarded a grant to the FDA’s National Center for Toxicological Research to conduct a study to better understand the effects of CBD exposure during pregnancy. Additionally, we’ve initiated a research study in partnership with the University of Mississippi to evaluate the levels of CBD and THC in a sample of cosmetic products to assess sensitization of THC and CBD topically, and dermal penetration.
As data become available that are high-quality, reliable and relevant to our evaluation of CBD products that fall under the FDA’s purview, we will be able to refine – and, perhaps in some cases, revise – our thinking and approaches.
Monitoring the Marketplace with a Focus on Greatest Risk to Public Harm
As we work to educate the public and close the knowledge gaps to further guide our approach to CBD products, we will continue to monitor the marketplace and take appropriate action against unlawful CBD products that pose a risk of harm to the public.
We have seen many CBD products being marketed with claims of therapeutic benefit, such as treating or curing serious diseases such as cancer and Alzheimer’s disease, or other drug claims, without having gone through the drug approval process. The proliferation of such products may deter consumers from seeking proven, safe medical therapies for serious illnesses – potentially endangering their health or life.
We also have serious concerns about products that put the public at risk in other ways. For example, we are aware of the risks posed by product contaminants such as heavy metals, THC or other potentially harmful substances. We also have significant concerns about products marketed with false claims or statements such as omitted ingredients, incorrect statements about the amount of CBD, products marketed for use by vulnerable populations like children or infants, and products that otherwise put the public health at risk.
As we move forward, we are currently evaluating issuance of a risk-based enforcement policy that would provide greater transparency and clarity regarding factors the agency intends to take into account in prioritizing enforcement decisions. Any enforcement policy would need to further the goals of protecting the public and providing more clarity to industry and the public regarding the FDA’s enforcement priorities while we take potential steps to establish a clear regulatory pathway.
Our ongoing efforts related to CBD, including the steps we’re announcing today, are in line with our mission to protect the public, foster innovation and promote consumer confidence. We recognize the significant public interest in CBD and we must work together with stakeholders and industry to develop high-quality data to close the substantial knowledge gaps about the science, safety and quality of many of these products. We are committed to working efficiently to further clarify our regulatory approach to these products – as always, using science as our guide and upholding our rigorous public health standards.
The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.
CALIFORNIA: Medical Marijuana, Inc., the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds Brasil, in partnership with the Consulate General of Brazil in Houston, sponsored “Autism Together We Are Stronger” at Rice University on February 22.
“We see events like this one as prime opportunities to educate people on what cannabidiol, or CBD, is and its potential benefits,” said HempMeds® Brasil Vice President Caroline Heinz. “CBD can be legally imported in Brazil and is even subsidized by the Brazilian government for many indications including autism. We want to do everything we can to help bring awareness to current research that is being conducted on how CBD can be used by people around the world.”
In addition to sponsoring the event, HempMeds® Brasil shared the event stage with two researchers who the Company has worked with frequently in the past, Dr. Alysson Muotri, Professor at the School of Medicine, University of California in San Diego, and Dr. Abram Topczewski, Neuropediatrician and Enuresis Clinic Director at the Albert Einstein Hospital.
“Education is the most important thing when it comes to helping the world become more accepting of cannabis and its compounds,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “We’re proud to be able to sponsor events like these and work with such prestigious doctors such as Dr. Muotri and Dr. Topczewski to help further medical research around the world.”
BY TYLER B. MARK, JONATHAN SHEPHERD, DAVID OLSON, WILLIAM SNELL, SUSAN PROPER, AND SUZANNE THORNSBURY
After a hiatus of almost 45 years, the 2014 Farm Bill reintroduced industrial hemp production in the United States through State pilot programs. This study documents outcomes and lessons learned from the State pilot programs and examines legal, agronomic, and economic challenges that may impact the transition from the pilot programs to economically viable commercial production.
In this publication…
MARYLAND: U.S. retail sales of cannabis and CBD products reached $14 billion in 2019, and are on pace to increase 18% per year to $33 billion in 2024, according to data published in Cannabis and CBD: U.S. Retail Market Trends and Opportunities, the latest report by leading market research firm Packaged Facts.
Cannabis products can be segmented by delivery format—i.e., the method by which the product’s desired compounds are ingested:
- The most common delivery format, flower—smoked in the form of buds or pre-rolled cigarettes—accounts for nearly 40% of retail sales.
- Another smokable product, vaporizer cartridges with concentrated THC or CBD compounds, comprises the second largest share. However, this share is falling as concerns about vaping-related lung illnesses rise and as states increasingly restrict sales of both nicotine- and cannabis-infused vaping products.
The fastest annual gains are projected for those delivery formats—namely edibles and topicals—that stand to benefit the most from federal legalization of hemp-based CBD. Major retailers—including foodservice establishments in certain states—are increasingly offering CBD-infused food, beverages, cosmetics, and toiletries that appeal to consumers because these products have the therapeutic benefits of CBD without the psychological effects of THC.
Other major delivery formats include tinctures, pills and capsules, and ingestible oils, which are used for both marijuana- and hemp-based products. Ingestible oils made from hemp seed oil (which does not include CBD or THC) have been available for decades and are used by health-conscious consumers for their purported nutritional benefits.
For more information on this emerging market purchase the report from our website.